- Home
- EAF vs PACB Comparison
EAF vs PACB Comparison
Compare EAF & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EAF
- PACB
- Stock Information
- Founded
- EAF 1886
- PACB 2000
- Country
- EAF United States
- PACB United States
- Employees
- EAF N/A
- PACB N/A
- Industry
- EAF Industrial Machinery/Components
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- EAF Energy
- PACB Industrials
- Exchange
- EAF Nasdaq
- PACB Nasdaq
- Market Cap
- EAF 437.2M
- PACB 449.1M
- IPO Year
- EAF 1995
- PACB 2010
- Fundamental
- Price
- EAF $1.76
- PACB $1.70
- Analyst Decision
- EAF Hold
- PACB Buy
- Analyst Count
- EAF 6
- PACB 13
- Target Price
- EAF $1.80
- PACB $2.92
- AVG Volume (30 Days)
- EAF 1.8M
- PACB 8.6M
- Earning Date
- EAF 02-07-2025
- PACB 02-13-2025
- Dividend Yield
- EAF N/A
- PACB N/A
- EPS Growth
- EAF N/A
- PACB N/A
- EPS
- EAF N/A
- PACB N/A
- Revenue
- EAF $541,710,000.00
- PACB $173,147,000.00
- Revenue This Year
- EAF N/A
- PACB N/A
- Revenue Next Year
- EAF $5.07
- PACB $19.89
- P/E Ratio
- EAF N/A
- PACB N/A
- Revenue Growth
- EAF N/A
- PACB 2.14
- 52 Week Low
- EAF $0.52
- PACB $1.16
- 52 Week High
- EAF $2.53
- PACB $7.50
- Technical
- Relative Strength Index (RSI)
- EAF 50.71
- PACB 41.01
- Support Level
- EAF $1.50
- PACB $1.59
- Resistance Level
- EAF $1.75
- PACB $2.22
- Average True Range (ATR)
- EAF 0.13
- PACB 0.17
- MACD
- EAF 0.02
- PACB -0.03
- Stochastic Oscillator
- EAF 65.00
- PACB 17.46
About EAF GrafTech International Ltd.
GrafTech International Ltd is a manufacturer of high-quality graphite electrode products essential to the production of EAF steel and other ferrous and non-ferrous metals. The company has only reportable segment, Industrial Materials, is comprised of its two major product categories: graphite electrodes and petroleum needle coke products. Petroleum needle coke is key raw material used in the production of graphite electrodes.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.